Lupin to acquire BiocomIllustrative image – not actual.

Lupin has entered the Russian market by acquiring 100% stake in Biocom, a fast-growing generic pharmaceuticals firm, for an undisclosed amount.


Russia is set to become one of the top eight pharmaceutical markets by 2018.


This is Lupin's second overseas acquisition this year. It had acquired 100% stake in Brazil's Medquimica for an undisclosed sum in May to mark its foray into the South American country.


 

← All latest storiesBack to top →